Pulmonary disease caused by Mycobacterium xenopi: The first case in Korea

Yonsei Medical Journal

Volumn 48, Issue 5, 2007, Pages 871-875

  Park, Hye Yun ^a   Koh, Won Jung ^a   Kwon, O Jung ^a   Lee, Nam Yong ^a   Shim, Young Mog ^a   Park, Young Kil ^b   Bai, Gill Han ^b   Mun, So Suk ^c   Kim, Bum Joon ^c  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Korean Institute of Tuberculosis   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Atypical mycobacteria; Korea; Mycobacterium xenopi

Indexed keywords

AMIKACIN; CLARITHROMYCIN; ETHAMBUTOL; ISONIAZID; KANAMYCIN; MOXIFLOXACIN; RIFAMPICIN; STREPTOMYCIN;

ACID FAST BACTERIUM; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; ATYPICAL MYCOBACTERIOSIS; BACTERIUM IDENTIFICATION; CASE REPORT; COUGHING; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FATALITY; GENERAL CONDITION DETERIORATION; HEARING; HEMOPTYSIS; HUMAN; KOREA; LUNG CAVITATION; LUNG INFECTION; LUNG INFILTRATE; LUNG LOBECTOMY; LUNG RESECTION; LUNG TUBERCULOSIS; MALE; MYCOBACTERIUM XENOPEI; RESPIRATORY FAILURE; SIDE EFFECT; SPUTUM CULTURE; THORAX RADIOGRAPHY;

AGED; BACTERIAL PROTEINS; HEAT-SHOCK PROTEINS; HUMANS; KOREA; LUNG DISEASES; MALE; MYCOBACTERIUM INFECTIONS, ATYPICAL; MYCOBACTERIUM XENOPI; PHYLOGENY; SEQUENCE ANALYSIS, DNA;

EID: 36248953688     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2007.48.5.871     Document Type: Article

References (20)

1. Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association. Am J Respit Crit Care Med 1997;156-S1-25.
2. Koh WJ, Kwon OJ, Lee KS. Diagnosis and treatment of nontuberculous mycobacterial pulmonary diseases; a Korean perspective. J Korean Med Sci 2005;20:913-25.
3. Jeon K, Koh WJ, Kwon OJ, Suh GY, Chung W, Kim H, et al. Recovery rate of NTM from AFB smear-positive sputum specimens at a medical centre in South Korea. Int J Tuberc Lung Dis 2005;9:1046-51.
4. Koh WJ, Kwon OJ, Jeon K, Kim IS, Lee KS, Park YK, et al. Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. Chest 2006;129:341-8.
5. Jenkins PA, Campbell IA, Research Committe of The British Thoracic Society. Pulmonary disease caused by Mycobacterium xenopi in HIV-negative patients: five year follow-up of patients receiving standardised, treatment Respir Med 2003;97:439-44.
6. Parrot RG, Grosset JH, Post-surgical outcome of 57 patients with Mycobacterium xenopi pulmonary infection. Tubercle 1988;69:47-55.
7. Simor AE, Salit IE, Vellend H. The role of Mycobacterium xenopi in human disease. Am Rev Respir Dis 1984;129: 435-8.
8. Yamazaki Y, Fujiuchi S, Matsumoto H, Takahashi T, Takeda A, Fujita Y, et al. Two cases of pulmonary Mycobacterium xenopi infection. Nihon Kokyuki Gakkai Zasshi 2003;41.556-60.
9. Kim H, Kim SH, Shim TS, Kim MN, Bai GH, Park YG, et al. PCR restriction fragment length polymorphism analysis (PRA)-algorithm targeting 644 bp Heat Shock Protein 65 (hsp65) gene for differentiation of Mycobacterium spp. J Microbiol Methods 2005;62:199-209.
10. Kim H, Kim SH, Shim TS, Kim MN, Bai GH, Park YG, et al. Differentiation of Mycobacterium species by analysis of the heat-shock protein 65 gene (hsp65). Int J Syst. Evol Microbiol. 2005;55:1649-56.
11. Falkinham JQ 3rd. Epidemiology of infection by nontuberculous mycobacteria. Clin Microbiol Rev 1996; 9:177-215.
12. Smith MJ, Citron M, Clinical review of pulmonary disease caused by Mycobacterium xenopi. Thorax 1983; 38:373-7.
13. Banks J, Hunter AM, Campbell IA, Jenkins PA, Smith AP. Pulmonary infection with Mycobacterium xenopi: review of treatment and response. Thorax 1964;39: 376-82.
14. Wittram, C, Weisbrod GL. Mycobacterium xenopi pulmonary infection: evaluation With CT, J Comput Assist Tomogr 1998;22:225-8.
15. Contreras MA, Cheung OT, Sanders DE, Goldstein RS. Pulmonary infection with nontuberculous mycobacteria. Am Rev Respir Dis 1988;137:149-52
16. Banks J, Jenkins PA. Combined versus single antituberculosis drugs on the in vitro sensitivity patterns of non-tuberculous mycobacteria. Thorax 1987;42:838-42.
17. Lounis N, Truffot-Pernot C, Bentoucha A, Robert J, Ji B, Grosset J. Efficacies of clarithromycin regimens against Mycobacterium xenopi in mice. Antimicrob Agents Chemother 2001;45:3229-30.
18. Majoor CJ, Schreurs AJ, Weers-Pothoff G. Mycobacterium xenopi infection in an immunosuppressed patient with Crohn's disease. Thorax 2004;59:631-2.
19. Schmitt H, Schnitzler N, Riehl J, Adam G, Sieberth HG, Haase G. Successful treatment of pulmonary Mycobacterium xenopi infection in a natural killer cell-deficient patient with clarithromycin, rifabutin, and sparfloxacin. Clin Infect Dis 1999;29:120-4.
20. Lang-Lazdunski L, Offredo C, Le Pimpec-Barthes F, Danel C, Dujon A, Riquet M. Pulmonary resection for Mycobacterium xenopi pulmonary infection. Ann Thorac Surg 2001;72:1877-82.